Phathom Pharmaceuticals Inc (PHAT)
R&D Expense Growth
-3.82%
Fiscal year · Period ending:
PHAT R&D Expense Growth
Latest reported-3.82%period ending
Latest reported-3.82%period ending
PHAT FY R&D Growth (YoY) (0.00% → -3.82%)
Latest values, visible window
High-resolution chart · PNG
PHAT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -3.8202% | |
| -31.698% | |
| -30.1536% | |
| -1.24% | |
| -26.297% | |
| -1.1312% | |
| 496,255% | |
| 0% |